Evidence map›Paper›PMID 40337574›Full record

ArticleCureus2025

Carbamazepine-Induced Oral Lichenoid Reaction: A Report of a Rare Case.

Gokhan Cinar, Ahmet Metin

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Treatments in oral lichen planus: a review.Frontiers in oral health · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gokhan CinarDepartment of Dermatology, Pamukkale University, Denizli, TUR.
Ahmet MetinDepartment of Dermatology, Pamukkale University, Denizli, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lichenoid drug reactions (LDRs) are rare adverse effects that resemble lichen planus both clinically and histopathologically. Although cutaneous involvement is more common, oral manifestations are relatively uncommon. Carbamazepine, a widely used antiepileptic drug, has been associated with various cutaneous adverse reactions, but oral lichenoid reactions (OLRs) due to carbamazepine are rarely reported. In this case report, we present a 62-year-old male patient who developed painful white reticular plaques on the buccal mucosa and lateral borders of the tongue after using carbamazepine for approximately 14 months. The lesions completely regressed within three weeks following the discontinuation of the drug. No dental restorations or other possible local irritants were detected. Although histopathological confirmation could not be obtained due to the patient's refusal of a biopsy, the clinical appearance and full remission after drug cessation strongly supported the diagnosis. This case highlights the importance of considering drug-induced OLRs in the differential diagnosis of oral mucosal lesions, especially in patients using medications known to cause lichenoid eruptions. Early recognition and discontinuation of the offending drug are crucial for resolution and patient comfort.

Indexed as

adverse drug reactionbuccal mucosacarbamazepinedrug-induced lesionsoral lichenoid reaction

Identifiers

PMID40337574
PMCPMC12057648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.